ThromboGenics to Present at the J.P. Morgan Annual Healthcare Conference 2015 in San Francisco
Leuven, Belgium – 22 December, 2014 - ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces that its Chief Executive Officer Dr Patrik De Haes will be presenting at the 33rd J.P. Morgan Annual Healthcare Conference (12-15 January, 2015).
Details of the presentation are as follows:
Date: 15 January 2015
Time: 10 am PST
Venue: Westin St. Francis Hotel, San Francisco, CA - Elizabethan C/ Victorian Room
Copies of the presentation will be made available at www.thrombogenics.com.